|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$85,233.57 |
2.79% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$82,222.99 |
2.70% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$77,278.34 |
2.53% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$76,544.20 |
2.51% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$74,484.09 |
2.44% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$72,377.03 |
2.37% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$71,973.90 |
2.36% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$69,845.76 |
2.29% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,824.32 |
2.29% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$69,550.89 |
2.28% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$69,203.94 |
2.27% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$69,049.75 |
2.26% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$69,049.04 |
2.26% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$69,005.67 |
2.26% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$68,437.39 |
2.24% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$68,022.28 |
2.23% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,055.70 |
2.20% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$66,382.70 |
2.18% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$66,064.77 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$64,920.32 |
2.13% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$64,328.80 |
2.11% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$63,504.00 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$63,316.84 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,474.85 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
265 |
$62,229.95 |
2.04% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$61,495.95 |
2.02% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$61,227.20 |
2.01% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$61,291.50 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,911.90 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$60,493.68 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$59,177.04 |
1.94% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,520.12 |
1.92% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$58,023.30 |
1.90% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$57,894.53 |
1.90% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,983.14 |
1.87% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$57,118.19 |
1.87% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$56,684.01 |
1.86% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$55,286.82 |
1.81% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,060.32 |
1.77% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$53,234.98 |
1.75% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$53,085.84 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$52,514.30 |
1.72% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$51,186.00 |
1.68% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,638.78 |
1.53% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$45,903.00 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,968.20 |
1.44% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$43,977.99 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,584.81 |
1.40% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$40,974.40 |
1.34% |
| US Dollar |
$USD |
|
14,959 |
$14,959.26 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|